Plus Therapeutics (PSTV) Other Working Capital Changes (2012 - 2026)
Plus Therapeutics (PSTV) reported Other Working Capital Changes of -$146000.0 for Q1 2026, down 97.3% year-over-year from -$5.4 million in Q1 2025, and down 1116.67% quarter-over-quarter from -$12000.0 in Q4 2025.
Plus Therapeutics (PSTV) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 15 years of Other Working Capital Changes data on file, last reported at -$146000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$146000.0, down 97.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$138000.0 (up 20.23% YoY), and the FY2025 annual result was -$66000.0, up 49.23% from the prior year.
- Other Working Capital Changes slipped to -$146000.0 in Q1 2026 per PSTV's latest filing, from -$12000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.4 million in Q3 2023 and troughed at -$1.5 million in Q2 2023.
- A 5-year average of -$34588.2 and a median of -$31000.0 in 2024 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1943.48% in 2022 and fell as far as 333.33% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$28000.0 in 2022, then fell by 7.14% to -$30000.0 in 2023, then dropped by 10.0% to -$33000.0 in 2024, then soared by 63.64% to -$12000.0 in 2025, then plunged by 1116.67% to -$146000.0 in 2026.
- Business Quant data shows PSTV's Other Working Capital Changes at -$146000.0 in Q1 2026, -$12000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | -34,000.00 |
| Sep 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -32,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Dec 31, 2023 | -30,000.00 |